KLOW 80 mg
Four-peptide blend in one vial (GHK-Cu, BPC-157, TB-500, KPV) · zero studies of the combination
KLOW is not a new peptide: it is a blend of four different peptides in one 80 mg vial. The name comes from the first letter of each. GHK-Cu is the copper-binding tripeptide that circulates in human plasma, described by Pickart in 1980 (citation 1). BPC-157 is the pentadecapeptide isolated from human gastric juice, whose literature comes almost entirely from a single Croatian group. TB-500 is a synthetic seven-amino-acid fragment of thymosin β4, identified in 2012 by an anti-doping laboratory that analyzed the product already being sold (citation 5). KPV is the last three amino acids of the hormone α-MSH. All four have their own entry in this catalog, with their own literature, their own level of evidence and their own gaps, and none is FDA-approved for use in people. We located no study, in any species, testing all four together in the same blend or in a product equivalent to KLOW.
Lyophilized powder: -20 °C, stable.
Articles
- GHK-Cu, the copper peptide: what the studies measured and what they did not
- KLOW, the four-part peptide: what is known about each part and what is not
- KLOW 80 mg: $160
For research use only. Not for human consumption.